ArticleScientific reports2026
A qualitative exploration of patient experiences living with autoimmune encephalitis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Autoimmune encephalitis (AE) can result in significant long-term sequelae including cognitive dysfunction, leading to a reduction in quality of life. While cohort studies have highlighted these difficulties broadly, we require a deeper understanding of the challenges facing these individuals in their day-to-day lives to provide better care and support. This qualitative descriptive study aimed to accurately capture the experiences of people living with AE across Australia and understand potential gaps in medical care. Inductive qualitative content analysis identified four key categories that have influenced participants and their carers experiences living with AE: (1) Access to quality medical care and factors that led to delays in diagnosis and treatment, (2) Chronic symptoms and their impact on their day-to-day lives, (3) Re-integration into premorbid life, and (4) Carer burden. Appropriate timely diagnosis and treatment was influenced by variation in clinician knowledge and available resources. Disparities in availability of medical care were observed between rural, metropolitan, primary, and tertiary care providers. Cognitive dysfunction, fatigue, and treatment-resistant seizures were common chronic symptoms that drove poor quality-of-life, changes to pre-morbid roles and social isolation. Together, access to quality care, high burden of chronic symptoms and poor social and healthcare supports contributed to carer overburden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.